The researchers investigated the incidence and predictors of venous thromboembolism in patients with acute myeloid leukemia or lymphoblastic leukemia by conducting a retrospective cohort study using data...
In a recent study, researchers sought to identify predictors associated with a higher risk of central nervous system relapse in patients with acute myeloid leukemia. To see results of the study, including...
After its efficacy was demonstrated in a clinical trial, the US Food and Drug Administration approved a new treatment options for adult patients with 2 types of poor-prognosis acute myeloid leukemia.
The US Food and Drug Administration recently approved a new treatment option for patients with relapsed or refractory acute myeloid leukemia who have IDH2 mutations.
Researchers conducted a trial to explore the benefits of including androgens into the maintenance therapy for acute myeloid leukemia in elderly patients.
